Viemed Healthcare Inc. (VMD) Financial Statements (2024 and earlier)

Company Profile

Business Address 625 E. KALISTE SALOOM RD.
LAFAYETTE, LA 70508
State of Incorp. BC
Fiscal Year End December 31
Industry (SIC) 809 - Miscellaneous Health And Allied Services, Not (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,30912,83910,07810,22423,54416,914
Cash and cash equivalents7,30912,83910,07810,22423,54416,914
Receivables24,47718,45117,92618,92216,32015,405
Inventory, net of allowances, customer advances and progress billings4,3494,6284,6704,4763,4473,574
Inventory4,3494,6284,6704,4763,4473,574
Other undisclosed current assets2,4832,4493,1872,3273,3943,849
Total current assets:38,61838,36735,86135,94946,70539,742
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization297401531538  
Operating lease, right-of-use asset2,7332,872461516  
Property, plant and equipment73,51173,57973,42372,88468,438 
Long-term investments and receivables2,6122,5392,5882,7052,7122,816
Long-term investments2,6122,5392,5882,7052,7122,816
Intangible assets, net (including goodwill)30,29930,33230,39230,447  
Goodwill29,76529,76529,70429,759  
Intangible assets, net (excluding goodwill)534567688688  
Deferred income tax assets4,5584,5583,9103,8443,8443,119
Other noncurrent assets 8878878878871,5961,590
Other undisclosed noncurrent assets1,3601,3601,3471,3471,33969,776
Total noncurrent assets:116,257116,528113,539113,16877,92977,301
TOTAL ASSETS:154,875154,895149,400149,117124,634117,043
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities19,85721,75822,69721,67617,07913,742
Accounts payable5,8004,1805,9786,1674,2622,650
Accrued liabilities14,05717,57816,71915,50912,81711,092
Deferred revenue6,0926,2076,2155,9604,6984,624
Debt7951,3282,1673,544  
Other undisclosed current liabilities3,3732,8314743951,644495
Total current liabilities:30,11732,12431,55331,57523,42118,861
Noncurrent Liabilities
Long-term debt and lease obligation6,0016,1348,27512,257  
Long-term debt, excluding current maturities5,9066,0028,09512,114  
Finance lease, liability95132180143  
Liabilities, other than long-term debt2,4842,7427587801,010889
Accounts payable and accrued liabilities4475585436371,010889
Operating lease, liability2,0372,184215143  
Other undisclosed noncurrent liabilities     162199
Total noncurrent liabilities:8,4858,8769,03313,0371,1721,088
Total liabilities:38,60241,00040,58644,61224,59319,949
Equity
Equity, attributable to parent116,273113,895108,814104,505100,04197,094
Common stock21,84218,70218,63317,85017,09615,123
Additional paid in capital14,29415,69814,16413,48812,08712,125
Retained earnings80,13779,49576,01773,16770,85869,846
Equity, attributable to noncontrolling interest      
Total equity:116,273113,895108,814104,505100,04197,094
TOTAL LIABILITIES AND EQUITY:154,875154,895149,400149,117124,634117,043

Income Statement (P&L) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Revenues50,59350,73949,40243,31139,55637,508
Cost of revenue
(Cost of Goods and Services Sold)
(20,791)(18,628)(18,840)(17,205)(15,552)(14,612)
Gross profit:29,80232,11130,56226,10624,00422,896
Operating expenses(26,192)(25,262)(24,944)(21,736)(20,760)(18,313)
Other undisclosed operating loss(1,406)(1,560)(1,412)(1,469)(1,310)(1,049)
Operating income:2,2045,2894,2062,9011,9343,534
Income from continuing operations before equity method investments, income taxes:2,2045,2894,2062,9011,9343,534
Income (loss) from equity method investments67432701373582
Other undisclosed income (loss) from continuing operations before income taxes(150)(256)(237)2049(32)
Income from continuing operations before income taxes:2,1215,0764,2393,0582,0183,584
Income tax expense(518)(1,599)(1,320)(728)(501)(1,146)
Net income:1,6033,4772,9192,3301,5172,438
Net loss attributable to noncontrolling interest      
Net income available to common stockholders, diluted:1,6033,4772,9192,3301,5172,438

Comprehensive Income ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Net income:1,6033,4772,9192,3301,5172,438
Comprehensive income:1,6033,4772,9192,3301,5172,438
Comprehensive loss, net of tax, attributable to noncontrolling interest      
Other undisclosed comprehensive loss, net of tax, attributable to parent      (56)
Comprehensive income, net of tax, attributable to parent:1,6033,4772,9192,3301,5172,382

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: